Can angiotensin-converting enzyme inhibitors reduce the incidence, severity, and duration of radiation proctitis?

Abduelmenem Alashkham (Lead / Corresponding author), Catherine Paterson, Petra Rauchhaus, Ghulam Nabi

Research output: Contribution to journalArticle

8 Citations (Scopus)
172 Downloads (Pure)

Abstract

Purpose: To determine whether participants taking angiotensin-converting enzyme inhibitors (ACEIs) and treated with radical radiation therapy with neoadjuvant/adjuvant hormone therapy have less incidence, severity, and duration of radiation proctitis.

Methods and Materials: A propensity score analysis of 817 patients who underwent radical radiation therapy with neoadjuvant or adjuvant hormone therapy as primary line management in a cohort study during 2009 to 2013 was conducted. Patients were stratified as follows: group 1, hypertensive patients taking ACEIs (as a study group); group 2, nonhypertensive patients not taking ACEIs; and group 3, hypertensive patients not taking ACEIs (both as control groups). The incidence, severity, and duration of proctitis were the main outcome. χ2 tests, Mann-Whitney U tests, analysis of variance, risk ratio (RR), confidence interval (CI), Kaplan-Meier plots, and log-rank tests were used.

Results: The mean age of the participants was 68.91 years, with a follow-up time of 3.38 years. Based on disease and age-matched comparison, there was a statistically significant difference of proctitis grading between the 3 groups: χ2 (8, n=308) = 72.52, P<.001. The Mann-Whitney U test indicated that grades of proctitis were significantly lower in hypertensive patients taking ACEIs than in nonhypertensive patients not taking ACEIs and hypertensive patients not taking ACEIs (P<.001). The risk ratio (RR) of proctitis in hypertensive patients taking ACEIs was significantly lower than in hypertensive patients not taking ACEIs (RR 0.40, 95% CI 0.30-0.53, P<.001) and in nonhypertensive patients not taking ACEIs (RR 0.58, 95% CI 0.44-0.77, P<.001). Time to event analysis revealed that hypertensive patients taking ACEIs were significantly different from the control groups (P<.0001). Furthermore, hypertensive patients taking ACEIs had significantly faster resolution of proctitis (P<.0001).

Conclusion: Patients who were taking ACEIs were significantly less likely to have high-grade proctitis after radical radiation therapy with neoadjuvant or adjuvant hormone therapy (P<.001). The intake of ACEIs was significantly associated with a reduced risk of radiation-induced proctitis and also with acceleration of its resolution.

Original languageEnglish
Pages (from-to)93-101
Number of pages9
JournalInternational Journal of Radiation Oncology Biology Physics
Volume94
Issue number1
Early online date18 Sep 2015
DOIs
Publication statusPublished - 1 Jan 2016

Keywords

  • Prostatic cancer
  • Radiotherapy
  • Proctitis
  • Angiotensin converting enzyme inhibitors
  • Pneumonitis
  • Nephritis

Fingerprint Dive into the research topics of 'Can angiotensin-converting enzyme inhibitors reduce the incidence, severity, and duration of radiation proctitis?'. Together they form a unique fingerprint.

  • Equipment

  • Cite this